WPD Pharmaceuticals's market cap is currently $608.44K. The company's EPS TTM is $-0.001; its P/E ratio is ―; WPD Pharmaceuticals is scheduled to report earnings on May 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ 0.00	C$ -24.44K	C$ -290.22K	C$ -391.77K	-
Operating Income	C$ -268.91K	C$ -2.33M	C$ -6.33M	C$ -8.46M	C$ -12.07M
EBITDA	C$ -40.43K	C$ 4.05M	C$ -5.24M	C$ -7.11M	C$ -3.39M
Net Income	C$ -80.08K	C$ 3.86M	C$ -5.62M	C$ -7.52M	C$ -12.78M
Balance Sheet
Cash & Short-Term Investments	C$ 85.86K	C$ 23.79K	C$ 1.71M	C$ 1.24M	C$ 2.95M
Total Assets	C$ 346.41K	C$ 75.85K	C$ 1.86M	C$ 2.68M	C$ 4.07M
Total Debt	C$ 303.90K	C$ 0.00	C$ 1.04M	C$ 115.38K	C$ 254.51K
Net Debt	C$ 218.04K	C$ -23.79K	C$ -664.57K	C$ -1.12M	C$ -2.70M
Total Liabilities	C$ 902.37K	C$ 554.64K	C$ 5.92M	C$ 1.58M	C$ 864.48K
Stockholders' Equity	C$ -555.96K	C$ -478.79K	C$ -4.06M	C$ 1.11M	C$ 3.21M
Cash Flow
Free Cash Flow	C$ -205.10K	C$ -3.47M	C$ -1.56M	C$ -2.03M	C$ -235.52K
Operating Cash Flow	C$ -205.10K	C$ -3.43M	C$ -1.49M	C$ -1.38M	C$ -170.40K
Investing Cash Flow	C$ 0.00	C$ -239.05K	C$ -70.98K	C$ -645.46K	C$ 2.81M
Financing Cash Flow	C$ 267.17K	C$ 1.23M	C$ 992.22K	C$ 1.02M	C$ 380.92K

Currency in CAD

WPD Pharmaceuticals Earnings and Revenue History

Income Statement >

WPD Pharmaceuticals Debt to Assets

Balance Sheet >

WPD Pharmaceuticals Cash Flow

Cash Flow >

WPD Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing